SCHEMBL27772020

SCHEMBL27772020

O=C(O)C(CN1CCCCCC1)c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.69
MITF O75030 3/20 0.69
SMN1; SMN2 Q16637 3/20 0.69
RAB9A P51151 2/20 0.69
HTT P42858 2/20 0.69
GFER P55789 1/20 0.69
PAX8 Q06710 1/20 0.69
ATM Q13315 1/20 0.69
NTSR1 P30989 2/20 0.63
LMNA P02545 3/20 0.58
HIF1A Q16665 1/20 0.58
MAPT P10636 1/20 0.52
NLRP1 Q9C000 1/20 0.52
GAA P10253 1/20 0.51
POLB P06746 1/20 0.51
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2596926 1.00 ALDH1A1 (0.69) ALDH1A1MITFSMN1; SMN2RAB9AHTT
Hydrochloric Acid SCHEMBL2551763 0.98 ALDH1A1 (0.72) ALDH1A1MITFSMN1; SMN2RAB9AHTT
SCHEMBL12282101 0.98 MITF (0.71) ALDH1A1MITFSMN1; SMN2RAB9AHTT
SCHEMBL7592795 0.98 MITF (0.71) ALDH1A1MITFSMN1; SMN2RAB9AHTT
SCHEMBL25107503 0.95 MITF (0.67) ALDH1A1MITFSMN1; SMN2RAB9AHTT
SCHEMBL11222652 0.87 MITF (0.66) ALDH1A1MITFSMN1; SMN2RAB9AHTT
SCHEMBL6321267 0.85 SMN1; SMN2 (0.94) ALDH1A1MITFSMN1; SMN2RAB9AHTT
SCHEMBL17616735 0.85 MITF (0.68) ALDH1A1MITFSMN1; SMN2RAB9AHTT
SCHEMBL1683001 0.84 LMNA (0.64) ALDH1A1MITFSMN1; SMN2RAB9AHTT
SCHEMBL9911024 0.83 ALDH1A1 (0.54) ALDH1A1MITFSMN1; SMN2RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101610813-A Quinuclidinol derivatives as muscarinic receptor antagonist ASTRAZENECA AB (SE) 2009-12-23 CN disclosed